SCHEMBL9998299

SCHEMBL9998299

CC/C(=C\c1ccc(CC)cc1)COC(C)=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.41
MAPT P10636 5/20 0.41
MEN1 O00255 5/20 0.41
NPSR1 Q6W5P4 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
AKR1C3 P42330 1/20 0.39
KDM4E B2RXH2 4/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
ALDH1A1 P00352 6/20 0.37
HPGD P15428 3/20 0.37
MAOB P27338 2/20 0.37
MAOA P21397 1/20 0.37
LMNA P02545 4/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
S1PR4 O95977 1/20 0.36
S1PR1 P21453 1/20 0.36
MAPK1 P28482 1/20 0.36
PKM P14618 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9998300 1.00 KMT2A (0.41) KMT2AMAPTMEN1NPSR1SMN1; SMN2
SCHEMBL9997788 0.88 MAPT (0.40) KMT2AMAPTMEN1NPSR1SMN1; SMN2
SCHEMBL9997786 0.88 MAPT (0.40) KMT2AMAPTMEN1NPSR1SMN1; SMN2
SCHEMBL9998510 0.88 THRB (0.41) KMT2AMAPTMEN1NPSR1SMN1; SMN2
SCHEMBL9998508 0.88 THRB (0.41) KMT2AMAPTMEN1NPSR1SMN1; SMN2
SCHEMBL9998444 0.86 LMNA (0.40) KMT2AMAPTMEN1NPSR1SMN1; SMN2
SCHEMBL9998443 0.86 LMNA (0.40) KMT2AMAPTMEN1NPSR1SMN1; SMN2
SCHEMBL9997631 0.85 ALDH1A1 (0.43) KMT2AMAPTMEN1NPSR1KDM4E
SCHEMBL9997632 0.85 ALDH1A1 (0.43) KMT2AMAPTMEN1NPSR1KDM4E
SCHEMBL9997802 0.84 KMT2A (0.53) KMT2AMAPTMEN1NPSR1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8558012-B2 2-fluoro-1,3-benzodithiol 1,1,3,3-tetraoxide derivative, production method thereof, and production method of monofluoromethyl group-containing compound using the same NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2013-10-15 US disclosed
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME NAGOYA INSTITUTE OF TECHNOLOGY (JP) 2011-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110319637-A1 2-FLUORO-1,3-BENZODITHIOL 1,1,3,3-TETRAOXIDE DERIVATIVE, PRODUCTION METHOD THEREOF, AND PRODUCTION METHOD OF MONOFLUOROMETHYL GROUP-CONTAINING COMPOUND USING THE SAME CBR1, CYP1B1, CYP2F1 KMT2A 2324/4885MAPT 2206/4885MEN1 1032/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.